F8 and hemophilia: In recent studies, the success rate of therapy for hemophilia based on current immune tolerance induction (ITI) protocols has been reported to be around 60% to 80% depending on several factors such as age at ITI start, race or ethnicity, FVIII genotype, and historical inhibitor peaks influencing the outcomes [11,12].